Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 14, 2025; 31(10): 101014
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.101014
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.101014
Figure 2 Lactococcus garvieae colonization aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic cholangitis.
A: Experimental flow chart; B: Representative images of liver sections stained with hematoxylin and eosin (original magnification, 100 × in the left panels and 200 × in the right panels; scale bars, 100 µm); C: Changes in body weight following the diet switch and Lactococcus garvieae treatment; D: Serum alkaline phosphatase, gamma-glutamyl transferase and alanine aminotransferase levels from each group are presented. All values are expressed as the mean ± SD; aP < 0.05 vs PBS group; bP < 0.01 vs PBS group; cP < 0.05 vs DDC + PBS group; DDC: 3,5-diethoxycarbonyl-1,4-dihydrocollidine; PBS: Phosphate-buffered saline; L. garv: Lactococcus garvieae; ALT: Alanine aminotransferase; ALP: Serum alkaline phosphatase; GGT: Gamma-glutamyl transferase.
- Citation: Liu M, Ji YL, Hu YJ, Su YX, Yang J, Wang XY, Chu HY, Zhang X, Dong SJ, Yang H, Liu YH, Zhou SM, Guo LP, Ran Y, Li YN, Zhao JW, Zhang ZG, Piao MY, Zhou L. Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption. World J Gastroenterol 2025; 31(10): 101014
- URL: https://www.wjgnet.com/1007-9327/full/v31/i10/101014.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i10.101014